Universita Degli Studi Di Trento
- Address
- Via Calepina 14, 38122 Trento, Italy
Universita Degli Studi Di Trento - Immunological and Rare Disease Research
The Universita Degli Studi Di Trento is actively engaged in advanced clinical research focusing on rare autoimmune and inflammatory conditions. The center demonstrates particular expertise in investigating novel therapeutic interventions for complex systemic diseases affecting multiple organ systems.
- Eosinophilic granulomatosis with polyangiitis (EGPA) and rare vasculitides
- Targeted biologic therapies and mechanism of action studies
- Randomized controlled trials in autoimmune disorders
The institution's research portfolio includes sophisticated phase 2b clinical trials examining the efficacy of innovative treatments such as Tezepelumab in maintaining disease remission. Their multicentre collaborative approach combines rigorous placebo-controlled methodology with detailed mechanistic investigations, contributing valuable insights into the pathophysiology and therapeutic management of rare eosinophilic disorders and systemic vasculitis.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Imperial College London Limited1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universita Degli Studi Di Trento
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Randomized, Double-Blind, Placebo-Controlled Study of Tezepelumab in Adults with Eosinophilic Granulomatosis with Polyangiitis (EGPA) | Imperial College London Limited | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Placebo | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.